Changzhou Zhongying Science & Technology Co Ltd
SZSE:300936
Balance Sheet
Balance Sheet Decomposition
Changzhou Zhongying Science & Technology Co Ltd
Current Assets | 793.8m |
Cash & Short-Term Investments | 528.7m |
Receivables | 211.3m |
Other Current Assets | 53.8m |
Non-Current Assets | 307.6m |
Long-Term Investments | 5m |
PP&E | 258.5m |
Intangibles | 34.3m |
Other Non-Current Assets | 9.8m |
Current Liabilities | 36.3m |
Accounts Payable | 20.9m |
Accrued Liabilities | 9.7m |
Short-Term Debt | 2.4m |
Other Current Liabilities | 3.3m |
Non-Current Liabilities | 29.6m |
Long-Term Debt | 24.3m |
Other Non-Current Liabilities | 5.3m |
Balance Sheet
Changzhou Zhongying Science & Technology Co Ltd
Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|
Assets | ||||||||
Cash & Cash Equivalents |
38
|
103
|
69
|
38
|
415
|
125
|
239
|
|
Cash |
0
|
0
|
0
|
0
|
415
|
125
|
239
|
|
Cash Equivalents |
38
|
103
|
69
|
38
|
0
|
0
|
0
|
|
Short-Term Investments |
0
|
0
|
10
|
0
|
50
|
350
|
290
|
|
Total Receivables |
81
|
72
|
120
|
195
|
148
|
171
|
211
|
|
Accounts Receivables |
55
|
51
|
71
|
122
|
112
|
125
|
136
|
|
Other Receivables |
26
|
21
|
49
|
73
|
37
|
45
|
75
|
|
Inventory |
25
|
31
|
31
|
34
|
56
|
48
|
49
|
|
Other Current Assets |
2
|
2
|
2
|
7
|
23
|
26
|
5
|
|
Total Current Assets |
146
|
207
|
231
|
275
|
693
|
721
|
794
|
|
PP&E Net |
31
|
46
|
112
|
139
|
219
|
254
|
259
|
|
PP&E Gross |
31
|
46
|
112
|
139
|
219
|
254
|
259
|
|
Accumulated Depreciation |
40
|
46
|
51
|
59
|
72
|
62
|
77
|
|
Intangible Assets |
8
|
30
|
29
|
29
|
28
|
26
|
32
|
|
Goodwill |
0
|
0
|
0
|
0
|
0
|
2
|
2
|
|
Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
5
|
|
Other Long-Term Assets |
2
|
1
|
3
|
2
|
5
|
12
|
10
|
|
Other Assets |
0
|
0
|
0
|
0
|
0
|
2
|
2
|
|
Total Assets |
186
N/A
|
284
+53%
|
375
+32%
|
445
+19%
|
945
+112%
|
1 016
+8%
|
1 101
+8%
|
|
Liabilities | ||||||||
Accounts Payable |
15
|
16
|
31
|
38
|
23
|
37
|
21
|
|
Accrued Liabilities |
7
|
6
|
5
|
6
|
8
|
10
|
10
|
|
Short-Term Debt |
6
|
6
|
29
|
40
|
21
|
5
|
2
|
|
Other Current Liabilities |
2
|
2
|
5
|
0
|
3
|
45
|
3
|
|
Total Current Liabilities |
30
|
30
|
70
|
85
|
55
|
97
|
36
|
|
Long-Term Debt |
0
|
0
|
3
|
0
|
0
|
23
|
24
|
|
Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
3
|
3
|
|
Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
Other Liabilities |
1
|
1
|
0
|
0
|
5
|
4
|
4
|
|
Total Liabilities |
30
N/A
|
30
0%
|
73
+144%
|
85
+16%
|
60
-29%
|
127
+111%
|
66
-48%
|
|
Equity | ||||||||
Common Stock |
53
|
56
|
56
|
56
|
75
|
75
|
75
|
|
Retained Earnings |
60
|
103
|
151
|
209
|
223
|
227
|
373
|
|
Additional Paid In Capital |
43
|
95
|
95
|
95
|
587
|
587
|
587
|
|
Total Equity |
156
N/A
|
254
+63%
|
302
+19%
|
360
+19%
|
885
+146%
|
889
+0%
|
1 035
+16%
|
|
Total Liabilities & Equity |
186
N/A
|
284
+53%
|
375
+32%
|
445
+19%
|
945
+112%
|
1 016
+8%
|
1 101
+8%
|
|
Shares Outstanding | ||||||||
Common Shares Outstanding |
53
|
56
|
56
|
56
|
75
|
75
|
75
|